Centre Hospitalo-Universitair Mustapha Pacha was founded in 1854 in the town of Moustapha and is the largest hospital in Algeria. This hospital center is one of 14 Centre Hospitalo-Universitair under the Algerian Ministry of Health, Population and Hospital Reform.

During the past decade, CHU Mustapha conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Mustapha" #1 collaborator was "Institut des Maladies Rares" with 1 trials as a collaborator and "National Research Agency, France" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CHU Mustapha" are "Acute Diarrhoea" (1 trials), "Cerebellar Ataxias" (1 trials) and "Spastic Paraplegias" (1 trials). Many other conditions were trialed in "CHU Mustapha" in a lesser frequency.

Most popular intervention types in "CHU Mustapha" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Smecta" (1 trials) and "Smecta placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Mustapha" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CHU Mustapha". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHU Mustapha, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Mustapha, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".